Indiva Successfully Imports 3 Premium CBD Strains from Swiss Cannabis Producer

LONDON, ON, Dec. 13, 2018 /CNW/ – Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (US:NDVAF) is pleased to announce it has successfully imported 3 premium CBD strains from Swiss cannabis producer Medropharm GmbH and Greenfields Health Care S.A. Having entered a strategic cooperation with the Swiss producer in 2017, Indiva’s CEO Niel Marotta has announced that the London-based company now has tissue cultures of the 3 strains propagating in their growth chamber.

We are proud to be the exclusive Canadian producer of these CBD strains, and pleased to enjoy a symbiotic relationship with Medropharm and Greenfields. Not only are we privileged to access these remarkable strains, we also have the benefit of their guidance and support during the cultivation process.

Niel Marotta, Indiva’s CEO

The 3 imported strains are remarkably high in CBD, and are ideally suited for medicinal users of cannabis. “Like Indiva, our Swiss partners are known for their commitment to improving their customers’ health and quality of life,” notes Marotta. “These strains and the products derived from them are going to help a lot of Canadians in pain.”

About Indiva

Indiva’s wholly owned subsidiary is licensed under the Cannabis Act and is a supplier of high quality, medical grade cannabis and cannabis products.  Indiva’s mission is to offer cannabis products that have a positive impact, improving lives and communities.

Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products.  In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, as well as Bhang Chocolate and other products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter